Surgical barriers possessing clinically important absorption characteristics

Patent metadata

Field	Value
Publication number	US-11535704-B2
Application number	US-201213624101-A
Country	US
Kind code	B2
Filing date	Sep 21, 2012
Priority date	Sep 23, 2011
Publication date	Dec 27, 2022
Grant date	Dec 27, 2022

Abstract

The present disclosure provides copolymers useful in medical devices. For example, the disclosure provides copolymers comprising the polymerization product ester block, ether blocks and diisocyanates. In certain embodiments, the disclosure provides a medical copolymer for implantation comprising ester blocks and ether blocks, wherein: the ester blocks comprise a negative free energy transfer and the ether blocks comprise a positive free energy transfer, the ether and ester blocks are less than 1/10 the length of said copolymer, and, the blocks are distributed such that no domain of contiguous blocks possessing the same polarity of free energy transfer are less than ⅓ of the molecular weight of the copolymer. The disclosure further provides methods of making the aforementioned polymers, and medical devices comprising the polymers.

First claim

What is claimed is:

1. A bioabsorbable polyurethane comprising a polymerization product of a prepolymer and a chain extender:
the polymerization product comprising polylactic acid diol, having a Mn of 1000, polyethylene glycol, having a Mn of 2000, isophorone diisocyanate, and
the chain extender is 1,4-butane diol, wherein a mole ratio with respect to the polylactic acid diol, polyethylene glycol, isophorone diisocyanate, and 1,4-butane diol is 2:1:10.1:7.1 respectively, and
wherein the bioabsorbable polyurethane degrades at a rate which retains 88% total molecular weight of the composition after 1 week as determined by storage in phosphate buffer solution at 37° C.

2. The bioabsorbable polyurethane of claim 1 , wherein the polylactic acid comprises poly(L-lactic acid), poly(D,L-lactic acid), or a combination thereof.

3. The bioabsorbable polyurethane of claim 1 , wherein the bioabsorbable polyurethane provides an anti-adhesion barrier when disposed about tissue.

4. The bioabsorbable polyurethane of claim 3 , wherein the polylactic acid diol and polyethylene glycol are arranged so that hydrophobic interactions with proteins is blocked.

5. The bioabsorbable polyurethane of claim 3 , wherein the bioabsorbable polyurethane is formed into an implantable sheet wherein the implantable sheet comprises a first side and a second side, wherein the first side includes the anti-adhesion barrier and the second side includes a cellular ingrowth support surface.

6. A bioabsorbable polyurethane comprising a polymerization product of a prepolymer and a chain extender:
the polymerization product comprising polylactic acid diol, having a Mn of 1000, polytetramethylene ether glycol, having a Mn of 2000, isophorone diisocyanate, and
the chain extender is 1,4-butane diol, wherein a mole ratio with respect to the polylactic acid diol, polytetramethylene glycol, isophorone diisocyanate, and 1,4-butane diol is 4:1:20.2:14.2 respectively, and
wherein the bioabsorbable polyurethane degrades at a rate which retains 50% total molecular weight of the composition after 1 week as determined by storage in phosphate buffer solution at 37° C.

7. The bioabsorbable polyurethane of claim 6 , wherein the polylactic acid comprises poly(L-lactic acid), poly(D,L-lactic acid), or a combination thereof.

8. The bioabsorbable polyurethane of claim 6 , wherein the bioabsorbable polyurethane provides an anti-adhesion barrier when disposed about tissue.

9. The bioabsorbable polyurethane of claim 8 , wherein the polylactic acid diol and polytetramethylene ether glycol are arranged so that hydrophobic interactions with proteins is blocked.

10. The bioabsorbable polyurethane of claim 8 , wherein the bioabsorbable polyurethane is formed into an implantable sheet wherein the implantable sheet comprises a first side and a second side, wherein the first side includes the anti-adhesion barrier and the second side includes a cellular ingrowth support surface.

Assignees

• Bvw Holding Ag

Inventors

• Wiese Hinrich
• Tessmar Joerg
• Kessler Martina
• Bluecher Lukas
• Milbocker Michael

Classifications

• C08G18/73

  acyclic · CPC title

• C08G18/4266

  prepared from hydroxycarboxylic acids and/or lactones · CPC title

• C08L2205/05

  containing polymer components which can react with one another · CPC title

• Y10T428/31554

  Next to second layer of polyamidoester · CPC title

• C08G2261/126

  block · CPC title